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Abstract
Studies on telomere and telomerase biology are funda-
mental to the understanding of aging and age-related
diseases such as cancer. However, human studies have
been hindered by differences in telomere biology
between humans and the classical murine animal model
system. In this paper, we describe basic studies of
telomere length and telomerase activity in canine
normal and neoplastic tissues and propose the dog as
an alternative model system. Briefly, telomere lengths
were measured in normal canine peripheral blood
mononuclear cells (PBMCs), a range of normal canine
tissues, and in a panel of naturally occurring soft tissue
tumours by terminal restriction fragment (TRF) analy-
sis. Further, telomerase activity was measured in canine
cell lines and multiple canine tissues using a combined
polymerase chain reaction /enzyme- linked immuno-
sorbent assay method. TRF analysis in canine PBMCs
and tissues demonstrated mean TRF lengths to range
between 12 and 23 kbp with heterogeneity in telomere
lengths being observed in a range of normal somatic
tissues. In soft tissue sarcomas, two subgroups were
identified with mean TRFs of 22.2 and 18.2 kbp.
Telomerase activity in canine tissue was present in
tumour tissue and testis with little or no activity in
normal somatic tissues. These results suggest that the
dog telomere biology is similar to that in humans and
may represent an alternative model system for studying
telomere biology and telomerase-targeted anticancer
therapies. Neoplasia (2001) 3, 351–359.
Keywords: telomere, telomerase, dog, cancer, model.
Introduction
Telomeres are specialised DNA–protein complexes that cap
the ends of linear chromosomes. In vertebrates, telomeres
consist of tandem repeats of the sequence TTAGGG and a
number of telomere-associated proteins. Telomeres main-
tain genomic integrity by protecting chromosome ends from
recombination, fusion, and from being recognised as DNA
damage [1–4]. In normal human somatic cells, telomeres
shorten with each cell division [5,6 ]. This telomeric attrition
has been attributed to the inability of the DNA replication
machinery to efficiently replicate the 50 ends of linear
chromosomes (end replication problem) [7,8 ]. Thus, telo-
meres shorten progressively with cell division, and telomere
shortening to a critical length has been proposed to limit the
lifespan of somatic cells in humans and play an important role
in the process of cellular senescence. Consistent with this
model, telomere shortening has been observed in vivo during
ageing of normal somatic tissues as well as in vitro cultured
human fibroblasts [9–11]. In addition, cells from patients with
premature ageing syndromes show evidence of premature
telomeric erosion [12,13].
In cells that proliferate indefinitely, such as germline cells
and transformed cells, the enzyme telomerase provides a
mechanism for the maintenance of telomere length. Telo-
merase is a ribonucleoprotein reverse transcriptase [4]
capable of synthesising terminal TTAGGG telomeric repeats,
thereby extending telomere length and compensating for
telomeric attrition during replication.
In adult human somatic tissues, telomeres are approx-
imately 10 to 15 kbp [14] and telomerase activity is low or
undetected in normal tissues but present in germ cells,
activated leukocytes, and stem cells from a variety of organs
[15–17]. Telomerase activity has been also detected in more
than 80% of cancer tissues in vivo and immortal cell lines
[18], suggesting that such tumours are dependent on
telomerase activity for their continued proliferation. In mice,
however, the situation is quite different; mice possess much
longer telomeres, and telomerase activity appears to be less
stringently regulated in somatic tissues [19–21].
Few studies have addressed telomere and telomerase
biology in the dog. The aim of this study was to investigate
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telomere lengths and telomerase activity in a range of
canine tissues including normal and tumour tissues.
Terminal restriction fragment (TRF) analyses were
employed to study telomeric lengths in 63 canine
peripheral blood mononuclear cell (PBMC) samples from
dogs of varying breeds and ages including samples from
puppies and geriatric dogs. This demonstrated mean TRFs
in the range of 12 to 23 kbp. TRF analysis in 18 canine
mesenchymal tumours identified two groups; one with a
mean TRF of 22.2 kbp and the other with a mean TRF of
18.2 kbp. TRFs were also evaluated in a panel of somatic
tissues from the same subject and demonstrated TRF
heterogeneity among different tissues. Further, telomeric
attrition was demonstrated during the in vitro culture of
canine primary fibroblasts. Using a combined polymerase
chain reaction (PCR)/enzyme- linked immunosorbent
assay (ELISA) method, telomerase activity was analysed
in multiple adult canine tissues derived from both tumour-
bearing and non–tumour-bearing dogs. Telomerase activ-
ity was detected in tumour and gonadal tissues with little
or no activity present in normal somatic tissues. Telomer-
ase activity was also assessed in a panel of canine
immortalised cell lines. High levels of telomerase activity
were detected in several canine cell lines. One cell line
(MDCK) was negative for enzyme activity, suggesting that
an alternative pathway for telomere maintenance may
operate in these cell types. Based on our finding, we
propose that the dog may represent an alternative model
system to study telomere biology in humans and inves-
tigate the efficacy of telomerase- targeted therapeutics for
cancer.
Materials and Methods
TRF Analysis
Canine blood samples PBMC-derived DNA was obtained
from EDTA and heparinised blood samples from canine
subjects using standard protocols. A total of 63 dogs of
various breeds were studied, ranging in age from 2 months to
15 years of age.
Normal somatic / tumour tissues from the same canine
subject Genomic DNA samples were isolated from a canine
subject which presented with multicentric lymphoma (case
B) and euthanised for medical reasons. Genomic DNA was
isolated from several tissues including testis, forelimb
muscle, spleen, stomach, liver, adrenal gland, and lym-
phoma tissue taken at post -mortem. Haematoxylin /eosin
sections of normal tissues confirmed them to be tumour- free
(data not shown).
Canine soft tissue sarcomas (STS) A total of 18 STS
samples were retrieved from the pathology archives of the
Department of Clinical Sciences of Companion Animals,
Faculty of Veterinary Medicine, University of Utrecht.
Samples had originally be taken either at biopsy, surgical
Figure 1. TRF distribution in canine DNA samples prepared from PBMCs. ( A ) TRF distribution in a panel of Retrievers of varying ages. The size and position of the
molecular weight markers are indicated on the left. Lane 1 mean TRF = 17.9 kbp; lane 2 mean TRF = 20.6 kbp; lane 3 mean TRF =15.1 kbp; lane 4 mean TRF =17.4
kbp; lane 5 mean TRF = 21.3 kbp; lane 6 mean TRF =18.0 kbp ( these data are an average of two analyses ). ( B ) TRF distribution showing short telomere lengths.
Lane 1, 1 - year -old Border Collie (mean TRF =12 kbp ); lane 2, 1 - year -old crossbreed ( mean TRF =17.9 kbp ).
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excision, or at post -mortem and archived at 708C.
Diagnosis was based upon histological analysis using
haematoxylin /eosin staining.
Cell culture Dermal fibroblasts were prepared from skin
biopsy tissue isolated from an 11-year-old dog at
post-mortem. Primary fibroblasts were cultured at 378C
in Dulbecco’s modified Eagle’s medium (DMEM, Invi-
trogen, Paisley, UK) supplemented with 10% foetal calf
serum and in the presence of 5% CO2. Population
doublings (PDs) were determined by cell counts upon
passage.
TRF analysis TRF analysis was performed by Southern Blot
Hybridisation using the Telomere Length Kit (BD PharMin-
gen, Oxford, UK). Briefly, high-molecular -weight genomic
DNA was isolated from blood and tissue samples by
digestion with proteinase K and extraction with phenol /
chloroform and verified by gel electrophoresis. Three micro-
grams of genomic DNA was digested with HinfI and RsaI
enzymes at 378C for 16 hours and subjected to 0.6%
agarose gel electrophoresis for 3 hours at 160 V. Digested
DNA was then transferred to Hybond N+ nylon membrane
(Amersham Pharmacia, Buckinghamshire, UK) and hybri-
dised with a biotinylated (TTAGGG)7 probe for 16 hours at
558C. Filters were washed in 2SSC/0.01% SDS and
subjected to chemiluminescence detection and exposed to
autoradiography film for 30 seconds. Biotinylated DNA
ladders and digested genomic DNA with known mean
telomeric repeat lengths were used as size markers. The
mean TRF length was calculated following image scanning
by integrating the signal intensity above background over the
entire TRF distribution as a function of TRF length using the
formulae: L=
P
(ODILI ) /
P
(ODI), where ODI and LI are the
signal intensity and TRF length, respectively, at position I on
the gel image. The peak telomere length was taken as being
the molecular weight corresponding to peak intensity. The
shortest TRF was estimated as the smallest signal that could
be detected.
Analysis of Telomerase Activity
Canine tissues Telomerase activity was assessed in a
range of tissues derived from three dogs that had been
euthanised for medical reasons. Cases A and B were
canine subjects which presented with lymphoma and case
C was a canine subject which presented with a non-
malignant condition. Canine samples examined included
thyroid, stomach, spleen, liver, kidney, heart, adrenal
gland, forelimb muscle, lymph node, testis, and lymphoma
tissues.
Figure 2. Plot and regression curve of the mean TRF against donor age in
canine Retrievers.
Figure 3. TRF patterns in PBMC -derived DNA samples from 2- month - old Minature Snauzers pups and geriatric Retrievers ( the mean TRFs for each sample are
shown in Table 1 ).
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Cell lines Telomerase activity was assessed in several
canine cell lines: CML10 (melanoma), MDCK (normal
kidney), D17 (osteosarcoma), A72 ( fibroblastoid tumour),
GHK (normal kidney), CMT3 (osteosarcoma), CMT7
(osteosarcoma), and CMT8 (osteosarcoma). In addition,
the human telomerase-positive SV40-transformed cell line
293T and the human telomerase-negative GM437 cell lines
were used as controls.
Assay for telomerase activity Telomerase activity was
measured using the Telomerase PCR/ELISA assay
(Roche, East Sussex, UK), following the manufacturer’s
recommended protocol. Tissue samples/cells were homo-
genised in 200 L of ice-cold lysis buffer and incubated
for 30 minutes on ice. After centrifugation at 16,000g for
20 minutes at 48C, the supernatant was collected, frozen
in liquid nitrogen, and stored at 808C. Protein concen-
tration was measured using the Bradford assay (Sigma,
Dorset, UK). Protein samples were incubated with reaction
buffer containing a biotin- labelled P1-TS primer and P2
primer, telomerase substrate, and Taq polymerase for 30
minutes at 258C in a final volume of 50 L. To each PCR
reaction, an internal standard ( IS) was included to detect
the presence of PCR inhibitors. After further incubation at
948C for 5 minutes, the resulting mixture was subjected to
the PCR for 30 cycles of 30 seconds at 948C, 30 seconds
at 508C, and 90 seconds at 728C. The amplification
products were denatured and hybridised with a digoxige-
nin- labelled, telomeric repeat-specific detection probe.
The resulting product was immobilised through the
biotin- labelled TS primer to a streptavidin-coated micro-
titer plate and detected with an antidigoxigenin antibody
Table 1. TRF Lengths in PBMC - Derived DNA Samples from Dogs of Varying
Ages and Breeds.
Breed Age Mean TRF Peak TRF Short TRF
( a ) TRF lengths in medium - sized canine breeds
Retriever 1 18 20.7 8.1
Retriever 2 17.8 19.5 8
Retriever 2 17.7 15.3 5
Retriever 2 17.4 23.1 9.6
Retriever 4 17.9 21.7 5
Retriever 4 17.8 23.4 11.8
Retriever 5 27.5 24.9 9
Retriever 5 20.6 21.8 11.5
Retriever 5 19.7 19.3 9.6
Retriever 5 18.4 24.9 9.8
Retriever 6 18.5 21.3 6.9
Retriever 7 21.3 22.8 10.6
Retriever 8 19.7 19.5 12.5
Retriever 9 20.4 21.8 8.4
Retriever 9 16.7 14.9 5
Retriever 9 22.1 29.7 11.8
Retriever 10 19.1 23.4 9.5
Retriever 10 16.4 24.4 11.5
Retriever 11 16.7 19.5 6.1
Retriever 12 15.1 19.2 5.5
Retriever 13 18.02 18.7 10.9
German Shepherd 1 16 20.5 8.9
German Shepherd 1 20 20 7.8
German Shepherd 7 21.2 20.6 11
German Shepherd 8 20.9 23.2 9.9
German Shepherd 9 21.9 20.6 12
Rottweiller 1 19.8 22.8 13.7
Rottweiller 2 19.4 26.1 10.6
Rottweiller 4 24.4 22.8 8.6
Border Collie 1 12 23.6 2.6
Border Collie 7 20.8 30 13.5
Greyhound 9 23 23 9.7
Greyhound 8 21.8 23.4 11.3
Greyhound 9 21.5 23.6 9.7
Greyhound 9 21.6 21 10.1
Crossbreed 1 17.9 26.7 10
Crossbreed 2 16.9 21.4 6.2
Crossbreed 4 19.1 24.1 12.0
Crossbreed 6 19.2 22.9 9.5
Crossbreed 7 27.6 23.8 14.5
Crossbreed 10 19.9 26.7 8.4
Crossbreed 12 19.4 22.9 4.4
Crossbreed 15 17.3 18.2 7
Bull Terrier 3 16.3 18.3 12.2
German Short Hair Pointer 7 20.4 21.5 10
English Setter 5 21.7 22.4 16.9
Lurcher 10 21.9 23.4 12.9
( b ) TRF lengths in large - sized canine breeds
Great Dane 1 14 16.6 5.2
Bull Mastiff 10 21.72 23 16.473
Bermese Mountain Dog 8 23.5 24.5 20
( c ) TRF lengths in small - sized canine breeds ( ages are given in years,
unless stated otherwise )
Minature Schnauzer 2 months 20.8 20.8 10.2
Minature Schnauzer 2 months 18.5 20.8 9.6
Minature Schnauzer 2 months 19.3 20 10.4
Breed Age Mean TRF Peak TRF Short TRF
Beagle 4 21.7 21.9 15.2
Beagle 12 18.7 18.5 9.4
Spaniel 1 19.2 22.4 16.5
Spaniel 7 14.8 26.6 6.4
Spaniel 11 23.5 23.5 19.8
Spaniel 12 16 20.2 7
West Highland White Terrier 2 12.3 13.5 5.4
West Highland White Terrier 10 22 30 15
Poodle 8 20.9 23.2 10.4
Papillon 5 19.2 19.7 13.6
Table 2. TRFs Values in Somatic and Tumour Tissues from the Same
Canine Subject.
Tissue Type Mean TRF Peak TRF Shortest TRF
Metastatic tumour 19.1 20.2 10.3
Lymphoma 22.8 20.9 14.6
Testis 14.4 19.8 4.1
Liver 13.5 14.4 6.9
Adrenal gland 17.8 22.2 9.6
Spleen 18.2 16.6 7.1
Forelimb muscle 21.1 22.8 11.1
Stomach 18.6 20.7 9.3
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conjugated with peroxidase. Absorbance values were
measured using a microtiter reader at 450 nm with a
reference wavelength of 690 nm. Samples were regarded
as telomerase-positive if the absorbance was higher
than 0.2 arbitrary units (A450 nmA690 nm). The
absorbance reading obtained with the positive control
supplied with the kit was always higher than 2.0 U. All
extracts were initially tested at 10 g/L of protein. In
cases where telomerase activity was undetectable at this
concentration, extracts were also tested at various con-
centrations ranging from 0.02 to 10 g/L of protein. All
assays were performed in duplicate. To evaluate the
presence of PCR inhibitors in protein extracts, samples
that were negative for telomerase activity were reassayed
for telomerase activity using the TeloTAGGG Telomerase
PCR/ELISAPLUS assay (Roche) using an IS following the
manufacturer’s recommended protocol.
Results
Mean TRFs in Canine Normal Tissues Range Between 12
and 23 kbp
TRFs were examined in a panel of 63 canine peripheral
blood samples derived from subjects of varying ages and
breeds by Southern blot hybridisation. A representative blot
is shown in Figure 1A. The results of this study are presented
in Table 1 and subjects are grouped according to breed and
breed size. The mean TRFs of all the samples analysed
ranged between 12 kbp and at least 23 kbp and the shortest
telomeric length detectable was approximately 2.6 kbp
(Figure 1B ). These data did not demonstrate any statistically
significant correlation between mean or peak TRF with donor
age. However, within the Retrievers ( representing the
largest group analysed), a trend indicating telomeric attrition
with increasing donor age was observed (Figure 2 ) (see
Discussion section). No obvious differences in TRFs were
evident between different breeds; however, Figure 3 shows
TRF analyses in three 2-month-old Minature Schanuzer
pups and three geriatric Retrievers aged 11 to 13 dogs (TRF
data are presented in Table 1). This demonstrates that
samples from older animals generate a greater smear
pattern than from young pups, suggesting that breed-
specific differences in telomere lengths may exist.
To evaluate whether tissue-specific differences in telo-
mere lengths exist in the dog, TRF analysis was performed in
a range of tissues derived from a dog, which presented with
multicentric lymphoma (case B). Normal somatic canine
tissues ( testis, forelimb muscle, spleen, stomach, liver,
adrenal gland) and lymphoma tissues were analysed.
Considerable variation in telomere lengths was demonstra-
ted among different tissues from the same subject with mean
TRF values ranging between 13.5 kbp and approximately 23
kbp (Table 2). The highest mean TRF value was detected in
multicentric lymphoma sites. The shortest mean TRF values
were detected in testis and liver tissue.
Two Groups of Canine STS are Identified by TRF Analysis
In order to evaluate the length of telomeres of STS,
mean TRFs, peak TRFs, and the shortest detectable
telomere lengths were estimated in a panel of 18 STS
(Table 3). All samples showed the presence of a single
peak. Six of the samples examined showed the presence
of a narrow TRF smear with mean TRFs ranging between
19.1 and 22.2 kbp and an average mean TRF of 22.2
kbp. The smallest telomere length detected in this group
was 13.1 kbp. The remaining 15 samples showed the
presence of variable heterogeneous TRFs ranging from as
Table 3. TRF Lengths in Canine Soft Tissue Sarcomas.
Tumour Histological Type Mean TRF Peak TRF Shortest TRF
Narrow TRF range
Spindle cell tumour 22.2 21.8 16
Liposarcoma 21.4 21.4 13
Malignant fibrous histiocytoma 22.2 21.7 16.8
Fibrosarcoma 20.9 21.7 15.1
Lymphoma 19.1 21.4 13.1
Synovial cell sarcoma 22.2 22.2 13.4
Broad TRF range
Spindle cell tumour 19.5 20.1 10
Spindle cell tumour 12.8 20.2 3.8
Nephroblastoma 14 19.1 7.6
Leiomyosarcoma 14.7 19.8 7.8
Leiomyosarcoma 17.5 20.8 7
Leiomyosarcoma 19.4 20.1 7
Leiomyosarcoma 16.7 21.8 6.1
Anaplastic sarcoma 18.3 22.2 6.6
Hemangiosarcoma 20 22.4 3.9
Chondrosarcoma 17.6 18.9 11.5
Neurofibrosarcoma 7.2 21.4 3.4
Rhabdomyosarcoma 15.5 19.1 3.5
Figure 4. Telomere length analysis of canine dermal fibroblasts in culture.
The size and position of the markers are indicated on the left and the PDs and
mean TRFs are shown.
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little as 3.4 kbp to approximately 23 kbp with mean TRFs
between 7.2 and 19.5 kbp and an average mean TRF of
18.2 kbp.
Telomeric Attrition Occurs During In Vitro Aging of Canine
Dermal Fibroblasts
Canine dermal fibroblasts were cultured in vitro for 16
PDs. DNA was isolated as various passages and
subjected to TRF analysis, and the results are shown in
Figure 4. The mean telomere length decreased with in
vitro aging from 20.5 kbp at passage 1 to 17.5 kbp at
passage 16.
Telomerase Activity is Confined to Germline and Tumour
Tissue in Dogs
Telomerase activity was assessed in a range of canine
tissue samples taken from three dogs (cases A, B, and C)
and the results are presented in Figure 5. No telomerase
activity could be demonstrated in thyroid, spleen, liver,
kidney, heart, adrenal gland, and forelimb muscle samples;
however, strong activity was observed in testis tissue and in
multicentric lymphoma samples. The levels of telomerase
activity in both tumour and testis material were similar in case
B. An absorbance value of 0.2 was taken as positive for
telomerase activity. Of the normal somatic tissues examined,
weak telomerase activity (A450 nm=0.18) was detected in
stomach tissue from case B. However, no activity was
detectable in stomach tissue taken from cases A and C.
Since it is possible that some tissue samples contain Taq
polymerase inhibitors, lack of telomerase activity was
confirmed by reassaying at various different protein concen-
trations and further confirmed by reassaying for telomerase
activity using the TRAP-PCR/ELISA method with an IS PCR
control.
Telomerase Activity is Demonstrated in Certain Canine Cell
Lines
Several canine cell lines were examined for telomerase
activity as shown in Figure 6. The highest levels of activity
( >0.7 U) were detected in CMT3 (1.12 U), CMT7 (0.82 U),
and CMT8 (0.71 U) cell lines. Telomerase activity >0.2 U
was also identified in CML10 (0.65 U), D17 (0.3 U), A72 (0.3
U), and GHK (0.20) cell lines, although the levels of activity
were lower than in the CMT3-8 lines. Telomerase activity
levels <0.2 U were detected in both MDCK (0.1 U) and the
human GHK cells (0.1 U), and these lines were considered
to be telomerase-negative.
Correlation Between Telomere Lengths and Telomerase
Activity
Telomere lengths were analysed in several tissues from
case B, which were also subjected to telomerase activity
assessment (Figure 5, Table 2). These tissues included: two
multicentric lymphoma sites, adrenal gland, stomach, liver,
spleen, testis, and forelimb muscle. The largest mean TRFs
were detected in multicentric lymphoma sites and both these
tissues showed high levels of telomerase activity, suggesting
that telomerase activity is associated with telomeric elonga-
tion. Although the mean TRFs varied among normal somatic
tissues including adrenal gland, liver, spleen, kidney, and
Figure 5. Telomerase activity in various canine tissues from three subjects ( A, B, C ). An absorbance ( A 450 nm ) > 0.2 is taken as positive for telomerase activity. LN
refers to lymph node. Cases A and B were canine subjects which presented with multicentric lymphomas and case C was a canine subject which presented with a
non -malignant condition.
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forelimb muscle ( ranging between 14.4 and 8.6 kbp), no
telomerase activity could be detected in these samples. A
high level of telomerase activity was identified in gonadal
tissue and this tissue demonstrated the smallest mean TRF
length.
Discussion
Telomeres play a critical role in determining the lifespan of
somatic cells. It has been proposed that telomeric attrition
upon successive cell divisions in somatic cells is circum-
vented in tumours and immortalised cells through activation
of telomerase, and the presence of telomerase activity may
be associated with the ability to proliferate indefinitely
( reviewed in Refs. [22,23] ). To evaluate the lengths of
telomeres in dogs, we analysed telomere lengths in canine
blood samples and a range of normal somatic tissues. Our
data indicate that canine telomeres consist of large hetero-
geneous telomeres with a mean TRF length ranging between
12 and 23 kbp.
The data presented in this paper do not demonstrate any
statistically significant correlation between the mean and
peak TRF lengths and donor age and/or breed. However, in
the Retriever group ( the largest group analysed), the trend is
towards telomeric attrition with increasing age, although not
statistically significant with the number of animals studied. To
further support age-related differences in telomere lengths,
the youngest dogs analysed in this study were 2 months of
age, demonstrating an average mean TRF of 19.3 kbp. In
comparison, the geriatric dogs (age range 11 to 13 years)
demonstrated an average mean TRF value of 17.1 kbp.
Although sample number prevents detailed statistical anal-
ysis, these data indicate that further investigation is
warranted with larger sample sizes. It is well documented
that lifespan among dogs is shortest in the large and giant
breeds, and longest in the small breeds. It is interesting to
note that the Great Dane, which is regarded as a large breed,
in this study was only 1 year of age and had a mean TRF
value of 14 kbp. Within the small breeds studied, one subject
(a West Highland White Terrier ) had a mean TRF value of
only 12.3 kbp at 2 years, compared to a dog of the same
breed with a mean TRF of 22 kbp at an age of 10 years.
Analysis of the TRF gel for this subject suggests that this dog
had a range of TRF lengths between 5.4 and 23 kbp.
However, the gel demonstrated marked heterogeneity in
telomere lengths in this subject, which is reflected in a low
mean TRF value compared to the 10-year-old subject of the
same breed. Although this result does not fit well with the
concept of age-related telomeric attrition or interbreed
variation in telomeric lengths, one explanation could be that
this subject has had a medical condition or treatment that has
affected telomeric lengths. A similar observation was found
in the Border Collies.
In PBMCs from humans of different ages, inverse
correlations between mean TRF length and donor age have
been reported [24–26] with a TRF length reduction at a rate
of approximately 20 to 40 bp per year [25]. The lack of
correlation demonstrated in the present study may reflect the
sample size and may be explained by genetically determined
interindividual heterogeneity in telomere lengths or breed-
specific differences in telomere lengths that may mask any
age-related correlation in telomere lengths. Telomere
lengths are most commonly measured as the mean TRF
by Southern blot hybridisation encompassing both the
telomeric and subtelomeric regions. In humans, subtelo-
meric sequences consist of approximately 2.5 kbp [27];
Figure 6. Telomerase activity in various canine cell lines. An absorbance ( A450 nm ) > 0.2 is taken as positive for telomerase activity. The GM437 line is a human
telomerase -negative cell line and the 293T cell line is a human -positive line.
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however, the size of subtelomeric sequences in dogs was
not elucidated in the present study. Analysis of a larger
number of canine breeds, using techniques such as
quantitative fluorescent in situ hybridisation and flow
cytometry methods [28,29], may identify variations in
telomere lengths and/or subtelomeric lengths between
different breeds. Although we were unable to demonstrate
a clear correlation between telomere loss and donor age,
telomere shortening was clearly evident during culture
propagation of canine dermal fibroblasts.
In this study, we were able to detect considerable
variation in the telomere lengths between different tissues;
testis and liver samples showed the lowest mean TRF with
the highest mean TRF detected in forelimb muscle. The
significance of low TRFs in testis and liver is uncertain, but
may have implications regarding the toxicity of telomerase
inhibitors. However, the low mean value for these tissues
may again reflect the high level of heterogeneity in TRFs in
these individual samples.
Telomere lengths were also studied in a panel of canine
STS. All samples showed the presence of a single peak with
little variation between peak TRFs. Based on the hybrid-
isation patterns and TRF values, we identified two sub-
groups: a narrow TRF range subgroup and a broad range
TRF subgroup. The mean TRFs of each group were 22.2 and
18.2 kbp, respectively. The latter subgroup demonstrated a
mean TRF value 4 kbp, less that identified in the remainder
of the STS. Although preliminary, these data indicate that the
significance of telomeric lengths in canine STS requires
further investigation by analysing comparative normal tissue
samples. Telomeric shortening and elongation occur fre-
quently in human tumours and have been reported by a
number of groups [30–32], although it appears this is not
uniform for all tumours, even for a particular histopatholog-
ical subtype. In addition, we examined telomere lengths in
two multicentric lymphoma sites and these tissues demon-
strated the presence of mean TRFs greater than those
detected in normal somatic tissues from the same subject.
Indeed, the multicentric lymphomas from this patient also
showed the presence of telomerase activity, further support-
ing telomere lengthening in these tumours. This study
provides evidence to support telomeric attrition and elonga-
tion in canine tumours and requires further validation in a
larger cohort of tumour types.
To further study telomere biology, we assessed telo-
merase activity in a wide range of normal somatic tissues
from dogs to evaluate the organismal distribution of
enzyme activity. Telomerase activity was detected in
canine tumour tissues with no evidence for activity in
normal somatic tissues, with the exception of testis.
Telomerase activity has previously been demonstrated in
over 95% of canine tumour tissues in a broad range of
tumour types [33,34]; however, the distribution of telomer-
ase activity in a wide range of normal somatic tissues has
not been evaluated. This paper provides the first compre-
hensive study of telomerase activity in normal somatic
tissues and demonstrates that the distribution of telomer-
ase activity among tissue in dogs is similar to humans, i.e.,
germinal tissues and tumour tissues have significant
telomerase, whereas other somatic tissues show low or
no activity. In humans, telomerase activity can also been
detected in cell renewal somatic cells, albeit at low levels
[15–17]. In the present study, a low level of telomerase
activity was detected in stomach tissue, but absent from
other somatic tissues. The results of this study therefore
suggest that telomerase activity in canine tissues is limited
to cells with high proliferative potential and telomerase may
therefore represent a useful tumour marker.
Several canine cell lines were also examined for
telomerase activity. The highest levels of activity were
detected in osteosarcoma cell lines (CMT3, CMT7, and
CMT8). Telomerase activity units was also identified in
melanoma (CML10) and a canine kidney cell line (GHK),
although the levels of activity were lower than in the CMT3-8
lines. Telomerase activity levels <0.2 U were detected in
MDCK cells and this line was considered to be telomerase-
negative.
Telomerase/ telomere biology is complicated by studies
which show that telomerase expression and telomere
lengths differ between humans and mice. Firstly, human
telomeres range between 5 and 15 kbp [14], whereas in
mice, telomeres are much larger, in the range of 40 to 60
kbp [19]. Although telomeric attrition occurs in mice and
generation six telomerase-deficient mice show the
expected conditions associated with shortened telomeres
including atrophy of organs, infertility, reduced stress
responses, and increased apoptosis [35–37], the regu-
lation of telomerase activity appears to differ between mice
and humans [38]. Secondly, while telomerase expression
is largely absent in human somatic tissues, expression is
evident in adult murine somatic tissues [37], and mouse
cells spontaneously immortalize, while human cells do not
[39]. These differences will have profound implications for
cancer research using murine models, as it is clear that
clinical applications involving the telomerase system cannot
be evaluated convincingly in the mouse. Further species
variation has been found in studies on chicken telomeres.
Venkatesan and Price [40] found that, although chicken
telomeres resemble human telomeres (8 to 20 kbp), the
distribution of telomerase activity in chickens resembles
that found in mice. However, decrease in telomerase
activity in adult chicken somatic tissues with age was
evident. In this study, we have clearly identified similarities
in telomere and telomerase biology in dogs and humans.
Although several important parameters remain to be
elucidated including telomere loss with ageing, telomerase
regulation in different tissues, and the identification of
canine telomerase gene sequences, our study proposes
the dog as an ideal model organism for in vivo telomerase
studies. The dog provides a naturally occurring outbred
model for many cancer types found in humans, and the
advantages of using the dog as a model have recently
been reported [41]. The dog may provide a situation that
could be exploited for studies on novel therapeutic
strategies involving telomerase targeting or inhibition and
telomerase-based gene therapy protocols.
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